Significance of metaphase II human oocyte morphology on ICSI outcome

Slides:

Advertisements

Similar presentations

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Advertisements

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Age at menarche: a predictor of diminished ovarian function?

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Michael M. Alper, M.D. Fertility and Sterility

The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis Guy Bibi, M.D.,

Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique.

Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time Patricia Fauque, M.D.,

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D. Fertility and Sterility

Hepatitis and reproduction

Neohormones as biomarkers of reproductive health

Medical treatment of ectopic pregnancy: a committee opinion

Konstantinos Pantos, M. D. , Evangelos Makrakis, M. D

Live birth of twins derived from zona-free oocytes

Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Predictive value of embryo grading for embryos with known outcomes

Limited importance of pre-embryo pronuclear morphology (zygote score) in assisted reproduction outcome in the absence of embryo cryopreservation Alessia.

Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in.

Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis Cui Hong Zheng, M.D., Ph.D.,

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Efficiency of slush nitrogen vitrification of human oocytes vitrified with or without cumulus cells in relation to survival rate and meiotic spindle competence

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss Michelle.

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

Fertility and Sterility

Zsolt P. Nagy, M. D. , Ph. D. , Laura F. Rienzi, Ph. D. , Filippo M

Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR Stacea Bowen, M.D., John Norian, M.D.,

Derivation of developmentally competent oocytes by in vitro culture of preantral follicles retrieved from aged mice Jung Kyu Choi, B.Sc., Jong Il Ahn,

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization David W. Schmidt, M.D.,,

Fertility and Sterility: an evaluation

Use of a modified intracytoplasmic sperm injection technique to overcome sperm-borne and oocyte-borne oocyte activation failures Jan Tesarik, M.D., Ph.D.,

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis Ernesto Bosch, M.D., Elena.

Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.

Current evaluation of amenorrhea

Fertility and Sterility

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Diane De Neubourg, M. D. , Kathelijne Mangelschots, B. Sc

In vitro sildenafil citrate use as a sperm motility stimulant

Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc

Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program Giovanni B. La Sala, M.D.,

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

Akash A. Kapadia, M. D. , Marcus Anthony, B. Sc

Mohamed Fawzy, M. D. , Mai Emad, B. Sc. , Mohamed Y. AbdelRahman, M. D

Presentation transcript:

Significance of metaphase II human oocyte morphology on ICSI outcome Laura Rienzi, B.Sc., Filippo Mari Ubaldi, M.D., Marcello Iacobelli, B.Sc., Maria Giulia Minasi, B.Sc., Stefania Romano, B.Sc., Susanna Ferrero, M.D., Fabio Sapienza, M.D., Elena Baroni, M.D., Katarzyna Litwicka, M.D., Ermanno Greco, M.D. Fertility and Sterility Volume 90, Issue 5, Pages 1692-1700 (November 2008) DOI: 10.1016/j.fertnstert.2007.09.024 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Relationship between female age (A), basal FSH on day 3 (B), FSH dose (IU) administrated during ovarian hyperstimulation (C), and number of retrieved oocytes (CCOCs) (D) and MOMS score. MOMS = metaphase II oocyte morphologic score. Fertility and Sterility 2008 90, 1692-1700DOI: (10.1016/j.fertnstert.2007.09.024) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions